{"id":49504,"date":"2022-10-11T19:02:23","date_gmt":"2022-10-11T17:02:23","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/"},"modified":"2022-10-11T19:02:23","modified_gmt":"2022-10-11T17:02:23","slug":"xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/","title":{"rendered":"XACT Robotics\u00ae Receives FDA Clearance for its ACE Xtend\u2122 Remote Control Unit"},"content":{"rendered":"
\n

\nFirst-of-its-kind capability allows users to robotically insert and steer instruments using the XACT ACE<\/i>\u00ae Robotic System directly from the control room<\/i>\n<\/p>\n

HINGHAM, Mass.–(BUSINESS WIRE)–XACT Robotics<\/a>\u00ae, developer of the world\u2019s first and only comprehensive robotic system for interventional procedures, announced today that its ACE Xtend\u2122 Remote Control Unit received U.S. Food and Drug Administration (FDA) clearance, allowing users to robotically insert and steer the XACT ACE\u00ae Robotic System remotely from the control room. The first-of-its-kind feature for CT-guided percutaneous procedures is designed to improve physician workflows while limiting physician and other users\u2019 exposure to radiation and reduce physical strain.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\n\u201cThe XACT ACE Robotic System has already allowed users to make percutaneous procedures, such as ablations, drainages and biopsies, more accurate, consistent and efficient,\u201d said Shai Meltzer, CEO of XACT Robotics. \u201cThe addition of ACE Xtend has the potential to further increase efficiencies for the care team with a streamlined workflow that helps reduce the time in which physicians and other users are exposed to harmful radiation during standard procedures.\u201d\n<\/p>\n

\n\u201cInterventional radiology is among the medical specialties that are facing a physician shortage in the coming years and technologies that can improve their efficiencies are crucial,\u201d said Jeffrey Solomon, MD, Vice President of Medical Affairs at XACT. \u201cBy equipping different users with tools that can standardize the procedure and potentially shorten procedure times, we can maximize the number of patients they see and help to mitigate the gap between the patient population and the physician population.\u201d\n<\/p>\n

\nThe comprehensive XACT ACE Robotic System is the first and only technology that combines image-based planning and monitoring with patented S-Drive\u2122 technology, which enables the system to quickly adapt from a linear to a non-linear trajectory with its robotic insertion and steering of instruments during interventional percutaneous procedures. It precisely delivers instruments to the designated targets with unparalleled accuracy, unmatched consistency, and unlimited efficiency.\n<\/p>\n

\nThe XACT ACE Robotic System has been proven to achieve unparalleled 1.7mm tip to target average accuracy upon first insertion based on data obtained from company clinical studies for biopsy procedures. By providing accurate and actionable results for medical diagnosis, the system aims to enhance early detection and improve patient outcomes.\n<\/p>\n

\nAbout XACT Robotics\u00ae<\/b>\n<\/p>\n

\nFounded in 2013, XACT Robotics\u00ae is advancing the field of radiology with cutting edge technology that supports earlier patient diagnosis and treatment. The company\u2019s XACT ACE\u00ae Robotic System is the world\u2019s first and only comprehensive robotic system that integrates image-guided planning and monitoring with patented S-Drive\u2122 technology to deliver various instruments to a desired target in the body with unparalleled accuracy, unmatched consistency, and unlimited efficiency. XACT Robotics is a privately held company with offices in Hingham, MA, USA and Caesarea, Israel.\n<\/p>\n

\nThe use of ACE Xtend\u2122 is limited to IR control rooms that have a window with clear and complete vision of the patient and the complete robot mounted on the patient, or a video camera set-up in the radiology procedure room that provides the same vision.<\/i>\n<\/p>\n

\nACE Xtend\u2122 can only be used after the first checkpoint in the procedure is reached.<\/i>\n<\/p>\n

\nFor more information and full system indication for use, visit <\/i>www.xactrobotics.com<\/i><\/a>.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia<\/b>
Dan Ventresca
\n
Matter Communications for XACT Robotics
\n
xact@matternow.com<\/a>
617.874.5488\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

First-of-its-kind capability allows users to robotically insert and steer instruments using the XACT ACE\u00ae Robotic System directly from the control room HINGHAM, Mass.–(BUSINESS WIRE)–XACT Robotics\u00ae, developer of the world\u2019s first and only comprehensive robotic system for interventional procedures, announced today that its ACE Xtend\u2122 Remote Control Unit received U.S. Food and Drug Administration (FDA) clearance, … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49504","6":"format-standard","7":"category-industry"},"yoast_head":"\nXACT Robotics\u00ae Receives FDA Clearance for its ACE Xtend\u2122 Remote Control Unit - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"XACT Robotics\u00ae Receives FDA Clearance for its ACE Xtend\u2122 Remote Control Unit - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"First-of-its-kind capability allows users to robotically insert and steer instruments using the XACT ACE\u00ae Robotic System directly from the control room HINGHAM, Mass.–(BUSINESS WIRE)–XACT Robotics\u00ae, developer of the world\u2019s first and only comprehensive robotic system for interventional procedures, announced today that its ACE Xtend\u2122 Remote Control Unit received U.S. Food and Drug Administration (FDA) clearance, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-11T17:02:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221011006015\/en\/1598531\/21\/Xtend_1.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"XACT Robotics\u00ae Receives FDA Clearance for its ACE Xtend\u2122 Remote Control Unit\",\"datePublished\":\"2022-10-11T17:02:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\\\/\"},\"wordCount\":548,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221011006015\\\/en\\\/1598531\\\/21\\\/Xtend_1.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\\\/\",\"name\":\"XACT Robotics\u00ae Receives FDA Clearance for its ACE Xtend\u2122 Remote Control Unit - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221011006015\\\/en\\\/1598531\\\/21\\\/Xtend_1.jpg\",\"datePublished\":\"2022-10-11T17:02:23+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221011006015\\\/en\\\/1598531\\\/21\\\/Xtend_1.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221011006015\\\/en\\\/1598531\\\/21\\\/Xtend_1.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"XACT Robotics\u00ae Receives FDA Clearance for its ACE Xtend\u2122 Remote Control Unit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"XACT Robotics\u00ae Receives FDA Clearance for its ACE Xtend\u2122 Remote Control Unit - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/","og_locale":"en_US","og_type":"article","og_title":"XACT Robotics\u00ae Receives FDA Clearance for its ACE Xtend\u2122 Remote Control Unit - Pharma Trend","og_description":"First-of-its-kind capability allows users to robotically insert and steer instruments using the XACT ACE\u00ae Robotic System directly from the control room HINGHAM, Mass.–(BUSINESS WIRE)–XACT Robotics\u00ae, developer of the world\u2019s first and only comprehensive robotic system for interventional procedures, announced today that its ACE Xtend\u2122 Remote Control Unit received U.S. Food and Drug Administration (FDA) clearance, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-11T17:02:23+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221011006015\/en\/1598531\/21\/Xtend_1.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"XACT Robotics\u00ae Receives FDA Clearance for its ACE Xtend\u2122 Remote Control Unit","datePublished":"2022-10-11T17:02:23+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/"},"wordCount":548,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221011006015\/en\/1598531\/21\/Xtend_1.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/","url":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/","name":"XACT Robotics\u00ae Receives FDA Clearance for its ACE Xtend\u2122 Remote Control Unit - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221011006015\/en\/1598531\/21\/Xtend_1.jpg","datePublished":"2022-10-11T17:02:23+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221011006015\/en\/1598531\/21\/Xtend_1.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221011006015\/en\/1598531\/21\/Xtend_1.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/xact-robotics-receives-fda-clearance-for-its-ace-xtend-remote-control-unit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"XACT Robotics\u00ae Receives FDA Clearance for its ACE Xtend\u2122 Remote Control Unit"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49504","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49504"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49504\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49504"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49504"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49504"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}